1Ji-Wu Han,Department of Gastroenterology,The 4th Hospital of Harbin Medical University,Harbin 150001,Heilongjiang Province,China Xiao-Rong Zhan,Xin-Yu Li,Bing Xia,Yue-Ying Wang,Jing Zhang,Department of Endocrinology,First Hospital of Harbin Medical University,Harbin 150001,Heilongjiang Province,China Bao-Xin Li,Department of Pharmacology,State Key Laboratory of Biomedicine and Pharmacology,Harbin Medical University,Harbin 150001,Heilongjiang Province,China.Impaired PI3K/Akt signal pathway and hepatocellular injury in high-fat fed rats[J].World Journal of Gastroenterology,2010,16(48):6111-6118. 被引量：22
5Fan J G,Farrell G C.Epidemiology of non-alcoholic fatty liver disease in China[J].J Hepatol,2009,50(1):204-210.
6Moi P,Chan K,Asunis I,et al.Isolation of NF-E2-related factor 2(Nrf2),a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region[J].Proc Natl Acad Sci USA,1994,91(21):9926-9930.
7Sriram N,Kalayarasan S,Sudhandiran G.Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling[J].Pulm Pharmacol Ther,2009,22(3):221-236.
8Chowdhry S,Nazmy M H,Meakin P J,et al.Loss of Nrf2markedly exacerbates nonalcoholic steatohepatitis[J].Free Radic Biol Med,2010,48(2):357-371.
9Whiteman E L,Cho H,Birnbaum M J.Role of Akt/protein kinase B in metabolism[J].Trends Endocrinol Metab,2002,13(10):444-451.
10Cai D,Yuan M,Frantz D F,et al.Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappa B[J].Nat Med,2005,11(2):183-190.
